1. Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, Matos-Bodden L, Leader B, Stadtmauer L. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. American Journal of Obstetrics & Gynecology. 2008.

2. LaMarca A, Grisendi V, Griesinger G. How Much Does AMH Really Vary in Normal Women? International Journal of Endocrinology. 2013

3. Nelson et al. “Anti- Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction. 2009

4. Pasqualini T, Chemes H, Rivarola M.A. Testicular testosterone levels during puberty in cryptorchidism. Clin. Endocrinol. 1981, (Oxf) 15, 545 -554.

5. La Marca et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 2006, Section of Obstetrics and Gynecology, University of Modena and Reggio Emilia, Policlinico of Modena, Via del Pozzo, 71, 41100 Modena, Italy 2Department of Medicine and Pharmacology, University of Messina, Messina, Italy.

6. La Marca A, Volpe A. AMH in female reproduction: is measurement of circulating AMH a useful tool? Clin. Endocrinol. 2006, 64, 603-610.

7 . Lee M.M, Misra M, Donahoe P.K, MacLaughlin D.T. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol. And Cell. Biotechnology. 2003, 211, 91-98.

8. Feyereisen E. et al. AMH: Clinical Insights into a Promising Biomarker of Ovarian Follicular Status. RBMOnline. 2006, 6, 695-703.

9. Visser J.A, deJong F.H, Laven J.S.E, Themmen A.P.N. AMH: A New Marker for Ovarian Function. Reproduction. 2006, 131, 1-9.

10. Van Disseldorp J, Faddy M.J, Themmen A.P.N, De Jong F.H, Peeters P.H.M, Van der Schouw Y.T, Broekmans F.J.M. Relationship of serum AMH concentration to age at menopause. J.Clin. Endocrinol. Metab. 2008, 93(6), 2129-34.